4-Nitrophenyl activated esters are superior synthons for indirect radiofluorination of biomolecules

Indirect radiolabelling has for a long time been the mainstay strategy for radiofluorination of biomolecules. Acylation of biomolecules through the use of an 18 F-labelled activated ester is a standard method for indirect radiolabelling. However, the preparation of 18 F-labelled activated esters is...

Full description

Saved in:
Bibliographic Details
Published in:RSC medicinal chemistry Vol. 11; no. 8; pp. 919 - 922
Main Authors: Haskali, Mohammad B, Farnsworth, Ashleigh L, Roselt, Peter D, Hutton, Craig A
Format: Journal Article
Language:English
Published: England 01-08-2020
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Indirect radiolabelling has for a long time been the mainstay strategy for radiofluorination of biomolecules. Acylation of biomolecules through the use of an 18 F-labelled activated ester is a standard method for indirect radiolabelling. However, the preparation of 18 F-labelled activated esters is typically a complex and multistep procedure. Herein, we describe the use of 4-nitrophenyl (PNP) activated esters to rapidly prepare 18 F-labelled acylation synthons in one step. Furthermore, we present a comparative study of PNP activated esters and the commonly utilised 2,3,5,6-tetrafluorphenyl (TFP) activated esters under direct radiofluorination conditions and demonstrate their relative acylation behaviour. We demonstrate the superiority of PNP esters under direct radiofluorination conditions with favourable acylation kinetics. A comparative study of PNP- and TFP-activated esters of radiolabelled prosthetic groups demonstrates the superiority of PNP esters in terms of stability and yields for use in one-step radiolabelling of small molecules and peptides.
Bibliography:10.1039/d0md00140f
Electronic supplementary information (ESI) available. See DOI
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:2632-8682
2632-8682
DOI:10.1039/d0md00140f